The client was involved in developing advanced molecular diagnostic products that would bring fast, accurate and low-cost diagnostics to a range of critical medical and scientific applications. The company was developing a low-cost instrument for real-time polymerase chain reactions (PCR). It believed that India would be one of the countries with real market potential. Thus, the client requested UC Strategy to assist in conducting a market assessment for nucleic acid sample collection and processing in India.
To assist the company in conducting the market assessment, UC Strategy adopted the following approach
- Estimated the market for nucleic acid sample collection and processing in India
- Developed a map of all the types of workflow protocols adopted by research and diagnostic labs in India
- Understood and highlighted reasons for switching from manual to automated workflow systems
- Understood the possible opportunities within the market, for the client
The client received a detailed implementation plan of integrated findings from the three assignments conducted for the client, included a plan to launch the testing platform, tests (kits) and sample processing platform (and kits).